Finding 1141767 (2023-002)

Significant Deficiency
Requirement
AB
Questioned Costs
-
Year
2023
Accepted
2025-06-18

AI Summary

  • Core Issue: There are significant deficiencies in how costs are allocated to the federal Opioid STR program, with several transactions lacking proper approval and documentation.
  • Impacted Requirements: Compliance with 2 CFR 200.403(e) and (f) is at risk due to inadequate internal controls and documentation practices.
  • Recommended Follow-Up: Establish formal written procedures to ensure all cost allocations are properly authorized and reviewed before being charged to federal programs.

Finding Text

Finding 2023-002: Significant Deficiency – Activities Allowed or Unallowed Assistance Listing Number (ALN): 93.788 Federal Program: Opioid STR Federal Agency: U.S. Department of Health and Human Services Pass-Through Entity: Minnesota Department of Human Services Federal Award Number: HT79TI083289 and H79TI085729 Federal Award Year: December 31, 2023 Criteria: 2 CFR 200.403(e) and (f) state that charges to federal awards must be determined in accordance with generally accepted accounting principles (GAAP) and be adequately documented. These records must be supported by a system of internal control which provides reasonable assurance that the charges are accurate, allowable, and properly allocated; and support the distribution of the or costs among specific activities or cost objectives if the expenses supported more than one federal award, or a federal award and non-federal award Condition/Context: Six of the forty non-payroll transactions that were tested did not have evidence of approval for the amount allocated to the federal program, one transaction was recorded in the incorrect period and one transaction did not have evidence of receipt. The Organization experienced an unusually elevated level of turn-over of key personnel in business operations during the period of time that the control procedures lapsed as the individuals replacing those responsible for attaining allocation authorizations were not yet hired or fully trained in their assignments. The sample was not a statistically valid sample. Cause: The Organization's control process for expenditure authorizations was not properly implemented. Effect: Inadequate controls over the allocation of costs could result in unallowable costs being improperly applied to the federal program. Questioned Costs: Not required Recommendation: The Organization should have formal written procedure to ensure that all relevant authorization and reviews have been completed before allocating costs to federal programs. Views of responsible officials: Management agrees with the auditors' finding and will take action to implement controlling procedures over federal programs.

Categories

Allowable Costs / Cost Principles

Other Findings in this Audit

  • 565325 2023-002
    Significant Deficiency
  • 565326 2023-003
    Significant Deficiency Repeat
  • 1141768 2023-003
    Significant Deficiency Repeat

Programs in Audit

ALN Program Name Expenditures
93.788 Opioid Str $802,685
14.239 Home Investment Partnerships Program $600,000
93.243 Substance Abuse and Mental Health Services Projects of Regional and National Significance $224,535
93.959 Block Grants for Prevention and Treatment of Substance Abuse $201,843
14.218 Community Development Block Grants/entitlement Grants $180,800
21.027 Coronavirus State and Local Fiscal Recovery Funds $61,447
93.946 Cooperative Agreements to Support State-Based Safe Motherhood and Infant Health Initiative Programs $1,988